India pharma exports have crossed the $28 billion mark in FY26, highlighting the sector’s resilience and steady growth despite global economic uncertainties.
Himachal Pradesh Chief Minister Sukhvinder Singh Sukhu inaugurated the Nuclear Medicine Block with PET scan at IGMC Shimla today, marking a major upgrade in the state’s public healthcare system.
Aurobindo Pharma has approved the generic formulations transfer of its domestic branded generic formulations products business to its wholly owned subsidiary, Auropharm.
AstraZeneca liver cancer therapy is making headlines after the company reported positive Phase III results, showing its combination approach significantly slows disease progression in patients.
US tariffs on patented pharma imports bring mixed impact for India, protecting generics but raising long-term risks for supply chains and investments.
Emami has signed a deal to acquire full stake in Axiom Ayurveda, marking its entry into the fast-growing health and wellness beverage segment.
India bioeconomy growth stands at USD 165.7 billion based on the latest government data, driven by biotech startups, policy support, and manufacturing push, strengthening its role in economic expansion.
Bayer simplifies access to Eylea 2mg in India, enabling early treatment for retinal diseases like Wet AMD and DME, improving patient access and reducing cost barriers.
Alkem Strengthens Ujjain Expansion as Alkem Laboratories on Thursday announced it will nearly double its investment to Rs 1,036 crore for a greenfield formulations manufacturing facility in Ujjain, Madhya Pradesh.
Emcure Pharmaceuticals has sharply cut the price of its weight loss drug Poviztra across India, slashing costs by an average of 47% to make the semaglutide based treatment more affordable for patients.The reduced pricing takes effect from April 3,
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")